Results 81 to 90 of about 12,357 (218)
Therapeutic effects of pentoxifylline on diabetic heart tissue via NOS
, 2016 Objective: Diabetes mellitus causes a decrease in cardiac output, arterial blood pressure, and heart rate. In this study, we aimed to investigate, at the molecular level, the effect of nitric oxide synthase (NOS) on heart pathology in type 1 diabetes and
KARABULUT, Derya +3 more
core +1 more source
Iranian Journal of Medical Sciences, 2013 Background: It was hypothesized that the use of Pentoxifylline would increase arterial O2 saturation and increase exercise tolerance in patients with Chronic Obstructive Pulmonary Disease (COPD).
Mohammad Javad Fallahi +2 more
doaj
Contemporary Clinical Dentistry, 2017 Aim and Objective: To evaluate the therapeutic efficacy of oral pentoxifylline in the treatment of oral submucous fibrosis (OSMF) patients by assessing the clinical symptoms such as burning sensation, mouth opening, and submucosal layer thickness and ...
Jayachandran Sadaksharam +1 more
doaj +1 more source
BMC Cardiovascular Disorders, 2018 Background Cilostazol has been associated with spontaneous reports of cardiovascular adverse events and serious bleeding. The objective of this study is to determine the relative risk of cardiovascular adverse events or haemorrhages in patients with ...
Jordi Real +9 more
doaj +1 more source
Pharmacology of pentoxifylline in isolated canine arteries and veins
, 1989 Pentoxifylline possesses vasodilator properties, but little information is available on the mechanism of action explaining this vasodilator effect. The present experiments were designed to determine the effects of the compound on vascular smooth muscle ...
Hoeffner, U +3 more
core +1 more source
Pentoxifylline in preterm neonates : a systematic review
, 2010 Sepsis, necrotizing enterocolitis (NEC), and chronic lung disease (CLD) in preterm neonates are associated with significant mortality and morbidity, including long-term neurodevelopmental impairment and socioeconomic burden.
Patole, Sanjay K. +2 more
core
The Renoprotective Potential of Pentoxifylline in Chronic Kidney Disease
, 2005 Current interventions with proven efficacy, such as glycemic and blood pressure control, dietary protein restriction, and angiotensin II blockade, slow the progression of chronic kidney disease (CKD); however, whether long-term cessation of CKD ...
Yung-ming Chen +11 more
core +1 more source
Partial Priapism Treated with Pentoxifylline [PDF]
, 2015 Main findings:A 26-year-old man suffering from partial priapism was successfully treated with a regimen including pentoxifylline, a nonspecific phosphodiesterase inhibitor that is often used to conservatively treat Peyronie's disease.Case hypothesis ...
Cooper, Meghan A. +5 more
core +1 more source
Italian Journal of Pediatrics, 2019 Introduction Pentoxifylline may be an important approach to treat neonatal sepsis. However, its use has not been well established. We conduct a systematic review and meta-analysis to evaluate the efficacy of pentoxifylline treatment for neonatal sepsis ...
Jun Tian +3 more
doaj +1 more source
Pentoxifylline: A New Agent for Intermittent Claudication
, 1985 Pentoxifylline is approved by the Food and Drug Administration for the treatment of patients with intermittent claudication on the basis of chronic occlusive arterial disease of the limbs.
Donald C. McLeod +2 more
core +1 more source